Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities.

Trzepizur W, Boursier J, Le Vaillant M, Ducluzeau PH, Dubois S, Henni S, Abraham P, Aubé C, Calès P, Gagnadoux F; on the behalf of the METABOL group.

Eur Respir J. 2018 Jun 7. pii: 1800601. doi: 10.1183/13993003.00601-2018. [Epub ahead of print]

PMID:
29880653
2.

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R.

N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519.

PMID:
29874528
3.

Criteria to Determine Reliability of Non-invasive Assessment of Liver Fibrosis With Virtual Touch Quantification.

Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V.

Clin Gastroenterol Hepatol. 2018 May 9. pii: S1542-3565(18)30470-1. doi: 10.1016/j.cgh.2018.04.062. [Epub ahead of print]

PMID:
29753082
4.

A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis.

Calès P, Boursier J, Oberti F, Moal V, Fouchard Hubert I, Bertrais S, Hunault G, Rousselet MC; multicentric groups (SNIFF, ANRS HC 23).

Hepatol Commun. 2018 Mar 5;2(4):455-466. doi: 10.1002/hep4.1161. eCollection 2018 Apr.

5.

Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH.

Boursier J, Anty R, Vonghia L, Moal V, Vanwolleghem T, Canivet CM, Michalak S, Bonnafous S, Michielsen P, Oberti F, Iannelli A, Van Gaal L, Patouraux S, Blanchet O, Verrijken A, Gual P, Rousselet MC, Driessen A, Hunault G, Bertrais S, Tran A, Calès P, Francque S.

Aliment Pharmacol Ther. 2018 May;47(10):1387-1396. doi: 10.1111/apt.14621. Epub 2018 Mar 25.

PMID:
29577364
6.

Effectiveness of a bipolar vessel sealant device for ovariohysterectomy in cats with pyometra.

Boursier JF, Bassanino J, Leperlier D.

J Feline Med Surg. 2018 Jan 1:1098612X17752581. doi: 10.1177/1098612X17752581. [Epub ahead of print]

PMID:
29359610
7.

Stabilization of Olecranon Fractures by Tension Band Wiring or Plate Osteosynthesis: A Retrospective Study of 41 Cases.

Fournet A, Boursier JF, Corbeau S, Decambron A, Viateau V, Fayolle P, Bedu AS, Leperlier D, Manassero M.

Vet Comp Orthop Traumatol. 2018 Jan;31(1):53-61. doi: 10.1160/VCOT-17-04-0057. Epub 2018 Jan 11.

PMID:
29325193
8.

Reply to: "Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FMVCTE algorithm" and to "Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes".

Boursier J, de Ledinghen V, Leroy V, Calès P.

J Hepatol. 2018 Mar;68(3):605-606. doi: 10.1016/j.jhep.2017.09.022. Epub 2017 Oct 4. No abstract available.

PMID:
28987517
9.

Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks.

Dayoub O, Le Lay S, Soleti R, Clere N, Hilairet G, Dubois S, Gagnadoux F, Boursier J, Martínez MC, Andriantsitohaina R.

Sci Rep. 2017 Aug 24;7(1):9378. doi: 10.1038/s41598-017-09933-4.

10.

Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy.

Calès P, Sacher-Huvelin S, Valla D, Bureau C, Olivier A, Oberti F, Boursier J, Galmiche JP; multicenter group VO-VCO.

Liver Int. 2018 Jan;38(1):84-93. doi: 10.1111/liv.13497. Epub 2017 Jul 7.

PMID:
28622450
11.

Determinants of sleep behavior in adolescents: A pilot study.

Gruber R, Somerville G, Paquin S, Boursier J.

Sleep Health. 2017 Jun;3(3):157-162. doi: 10.1016/j.sleh.2017.03.004. Epub 2017 Apr 8.

PMID:
28526252
12.

Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance.

Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J.

Diagn Interv Imaging. 2017 Jun;98(6):455-468. doi: 10.1016/j.diii.2017.03.003. Epub 2017 Apr 29.

13.

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C - authors' reply.

Calès P, Boursier J.

Aliment Pharmacol Ther. 2017 May;45(9):1276-1277. doi: 10.1111/apt.14032. No abstract available.

PMID:
28370034
14.

Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C.

Chindamo MC, Boursier J, Luiz RR, Fouchard-Hubert I, Pannain VL, de Araújo Neto JM, Coelho HS, de Mello Perez R, Calès P, Villela-Nogueira CA.

World J Hepatol. 2017 Feb 28;9(6):310-317. doi: 10.4254/wjh.v9.i6.310.

15.

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Calès P, Boursier J, Lebigot J, de Ledinghen V, Aubé C, Hubert I, Oberti F.

Aliment Pharmacol Ther. 2017 Apr;45(7):991-1003. doi: 10.1111/apt.13954. Epub 2017 Feb 6.

PMID:
28164327
16.

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.

Boursier J, de Ledinghen V, Leroy V, Anty R, Francque S, Salmon D, Lannes A, Bertrais S, Oberti F, Fouchard-Hubert I, Calès P.

J Hepatol. 2017 Jun;66(6):1158-1165. doi: 10.1016/j.jhep.2017.01.003. Epub 2017 Jan 12.

PMID:
28088581
17.

Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.

Bertrais S, Boursier J, Ducancelle A, Oberti F, Fouchard-Hubert I, Moal V, Calès P.

J Gastroenterol Hepatol. 2017 Jun;32(6):1240-1249. doi: 10.1111/jgh.13668.

PMID:
27897323
18.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F.

J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338.

PMID:
26992056
19.

Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.

Trzepizur W, Boursier J, Mansour Y, Le Vaillant M, Chollet S, Pigeanne T, Bizieux-Thaminy A, Humeau MP, Alizon C, Goupil F, Meslier N, Priou P, Calès P, Gagnadoux F; Institut de Recherche en Santé Respiratoire des Pays de la Loire Sleep Cohort Group.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1657-1661. doi: 10.1016/j.cgh.2016.04.037. Epub 2016 May 5.

PMID:
27155555
20.

Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?

Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P.

J Hepatol. 2017 Feb;66(2):304-312. doi: 10.1016/j.jhep.2016.10.006. Epub 2016 Oct 13.

PMID:
27743987
21.

Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

Hocquelet A, Aubé C, Rode A, Cartier V, Sutter O, Manichon AF, Boursier J, N'kontchou G, Merle P, Blanc JF, Trillaud H, Seror O.

J Hepatol. 2017 Jan;66(1):67-74. doi: 10.1016/j.jhep.2016.07.010. Epub 2016 Jul 13.

PMID:
27422750
22.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V.

J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.

PMID:
27151181
23.

Nonalcoholic Fatty Liver Disease and the Gut Microbiome.

Boursier J, Diehl AM.

Clin Liver Dis. 2016 May;20(2):263-75. doi: 10.1016/j.cld.2015.10.012. Epub 2015 Dec 24. Review.

PMID:
27063268
24.

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults.

Monseu M, Dubois S, Boursier J, Aubé C, Gagnadoux F, Lefthériotis G, Ducluzeau PH.

Diabetes Metab. 2016 Nov;42(5):364-367. doi: 10.1016/j.diabet.2016.02.004. Epub 2016 Mar 24.

PMID:
27016890
25.

Reply.

Boursier J, Barret M, Diehl AM.

Hepatology. 2016 Sep;64(3):994-5. doi: 10.1002/hep.28562. Epub 2016 Apr 18. No abstract available.

26.

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A; GOLDEN-505 Investigator Study Group.

Gastroenterology. 2016 May;150(5):1147-1159.e5. doi: 10.1053/j.gastro.2016.01.038. Epub 2016 Feb 11. Erratum in: Gastroenterology. 2017 Jun;152(8):2084.

27.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.

Cassinotto C, Boursier J, de Lédinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, Mouries A, Oberti F, Fouchard-Hubert I, Vergniol J, Aubé C.

Hepatology. 2016 Jun;63(6):1817-27. doi: 10.1002/hep.28394. Epub 2016 Jan 22.

PMID:
26659452
28.

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Calès P, Diehl AM.

Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.

29.

Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?

Cartier V, Boursier J, Lebigot J, Oberti F, Fouchard-Hubert I, Aubé C.

J Gastroenterol Hepatol. 2016 Mar;31(3):654-60. doi: 10.1111/jgh.13179.

PMID:
26414644
30.

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients.

Boursier J, Ducancelle A, Vergniol J, Veillon P, Moal V, Dufour C, Bronowicki JP, Larrey D, Hézode C, Zoulim F, Fontaine H, Canva V, Poynard T, Allam S, De Lédinghen V; ANRS CO20 CUPIC Study Group.

J Viral Hepat. 2015 Dec;22(12):1002-10. doi: 10.1111/jvh.12433. Epub 2015 Jul 27.

PMID:
26216230
31.

Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease.

Machado MV, Michelotti GA, Xie G, de Almeida TP, Boursier J, Bohnic B, Guy CD, Diehl AM.

PLoS One. 2015 Jun 29;10(6):e0132315. doi: 10.1371/journal.pone.0132315. eCollection 2015. No abstract available.

32.

Screening for significant chronic liver disease by using three simple ultrasound parameters.

Lignon G, Boursier J, Delumeau S, Michalak-Provost S, Lebigot J, Oberti F, Aubé C.

Eur J Radiol. 2015 Aug;84(8):1466-1472. doi: 10.1016/j.ejrad.2015.05.017. Epub 2015 May 19.

PMID:
26032127
33.

Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.

Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, Guy CD, Diehl AM.

PLoS One. 2015 May 27;10(5):e0127991. doi: 10.1371/journal.pone.0127991. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0132315. de Almeida, Thiago Pereira [corrected to Almeida Pereira, Thiago].

34.

Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests.

Guéchot J, Boursier J, de Ledinghen V, Poynard T, Carrat F, Leroy V, Wong GL, Friedrich-Rust M, Fraquelli M, Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P; ARDENT group and/or AFEF.

Clin Chem Lab Med. 2015 Jul;53(8):1135-7. doi: 10.1515/cclm-2015-0241. No abstract available.

35.

Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.

Louvet A, Labreuche J, Artru F, Boursier J, Kim DJ, O'Grady J, Trépo E, Nahon P, Ganne-Carrié N, Naveau S, Diaz E, Gustot T, Lassailly G, Cannesson-Leroy A, Canva-Delcambre V, Dharancy S, Park SH, Moreno C, Morgan TR, Duhamel A, Mathurin P.

Gastroenterology. 2015 Aug;149(2):398-406.e8; quiz e16-7. doi: 10.1053/j.gastro.2015.04.044. Epub 2015 Apr 29.

PMID:
25935634
36.

MRI versus histological methods for time course monitoring of steatosis amount in a murine model of NAFLD.

Leiber LM, Boursier J, Michalak S, Roullier V, Fizanne L, Chaigneau J, Roux J, Moal V, Flamment M, Bazeries P, Ducluzeau PH, Aube C.

Diagn Interv Imaging. 2015 Sep;96(9):915-22. doi: 10.1016/j.diii.2015.03.006. Epub 2015 Apr 28.

37.

Implication of gut microbiota in nonalcoholic fatty liver disease.

Boursier J, Diehl AM.

PLoS Pathog. 2015 Jan 27;11(1):e1004559. doi: 10.1371/journal.ppat.1004559. eCollection 2015 Jan. No abstract available.

38.

An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.

Boursier J, de Ledinghen V, Poynard T, Guéchot J, Carrat F, Leroy V, Wong GL, Friedrich-Rust M, Fraquelli M, Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P; ARDENT group; AFEF.

J Hepatol. 2015 Apr;62(4):807-15. doi: 10.1016/j.jhep.2014.10.042. Epub 2014 Nov 5.

PMID:
25450206
39.

Patatin-like phospholipase domain-containing protein 3 and liver disease: opportunities to unravel mechanisms underlying statistical associations.

Boursier J, Diehl AM.

Hepatology. 2015 Jan;61(1):18-20. doi: 10.1002/hep.27445. Epub 2014 Nov 25. No abstract available.

PMID:
25234690
40.

IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.

Miot C, Beaumont E, Duluc D, Le Guillou-Guillemette H, Preisser L, Garo E, Blanchard S, Hubert Fouchard I, Créminon C, Lamourette P, Fremaux I, Calès P, Lunel-Fabiani F, Boursier J, Braum O, Fickenscher H, Roingeard P, Delneste Y, Jeannin P.

Gut. 2015 Sep;64(9):1466-75. doi: 10.1136/gutjnl-2013-306604. Epub 2014 Sep 2.

PMID:
25183206
41.

IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells.

Preisser L, Miot C, Le Guillou-Guillemette H, Beaumont E, Foucher ED, Garo E, Blanchard S, Frémaux I, Croué A, Fouchard I, Lunel-Fabiani F, Boursier J, Roingeard P, Calès P, Delneste Y, Jeannin P.

Hepatology. 2014 Dec;60(6):1879-90. doi: 10.1002/hep.27328. Epub 2014 Oct 29.

PMID:
25066464
42.

Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.

Machado MV, Michelotti GA, Pereira Tde A, Boursier J, Kruger L, Swiderska-Syn M, Karaca G, Xie G, Guy CD, Bohinc B, Lindblom KR, Johnson E, Kornbluth S, Diehl AM.

Gut. 2015 Jul;64(7):1148-57. doi: 10.1136/gutjnl-2014-307362. Epub 2014 Jul 22.

43.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-Hubert I, Oberti F, Rousselet MC, Calès P.

Aliment Pharmacol Ther. 2014 Jul;40(2):178-88. doi: 10.1111/apt.12813. Epub 2014 Jun 2.

44.

Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test.

Calès P, Boursier J, Oberti F, Bardou D, Zarski JP, de Lédinghen V; Multicentric Group.

J Clin Gastroenterol. 2015 Jul;49(6):512-9. doi: 10.1097/MCG.0000000000000138.

PMID:
24828359
45.

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.

Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, Chermak F, Hubert IF, Merrouche W, Oberti F, de Lédinghen V, Calès P.

Hepatology. 2014 Jul;60(1):65-76. doi: 10.1002/hep.27069.

PMID:
24519328
46.

Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C.

Sandrini J, Boursier J, Chaigneau J, Sturm N, Zarski JP, Le Bail B, de Ledinghen V, Calès P, Rousselet MC.

Mod Pathol. 2014 Jul;27(7):1035-45. doi: 10.1038/modpathol.2013.225. Epub 2014 Jan 3.

47.

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.

Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study.

Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16.

PMID:
24102852
48.

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

Mathurin P, Louvet A, Duhamel A, Nahon P, Carbonell N, Boursier J, Anty R, Diaz E, Thabut D, Moirand R, Lebrec D, Moreno C, Talbodec N, Paupard T, Naveau S, Silvain C, Pageaux GP, Sobesky R, Canva-Delcambre V, Dharancy S, Salleron J, Dao T.

JAMA. 2013 Sep 11;310(10):1033-41. doi: 10.1001/jama.2013.276300.

PMID:
24026598
49.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR.

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
50.

Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds.

Boursier J, Rawls JF, Diehl AM.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):876-8. doi: 10.1016/j.cgh.2013.04.016. Epub 2013 Apr 26. No abstract available.

PMID:
23628504

Supplemental Content

Loading ...
Support Center